A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer
Clinical trial NCT01363986 · TERMINATED
Trial details
- NCT number
- NCT01363986
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-06-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.